Skip to main content
Top
Published in: Familial Cancer 1/2013

01-03-2013 | Original Article

Psychosocial factors and uptake of risk-reducing salpingo-oophorectomy in women at high risk for ovarian cancer

Authors: Bettina Meiser, Melanie A. Price, Phyllis N. Butow, Janan Karatas, Judy Wilson, Louise Heiniger, Brandi Baylock, Margaret Charles, Sue-Anne McLachlan, Kelly-Anne Phillips

Published in: Familial Cancer | Issue 1/2013

Login to get access

Abstract

Bilateral risk-reducing salpingo-oophorectomy (RRSO) has been shown to significantly reduce the risk of ovarian cancer. This study assessed factors predicting uptake of RRSO. Women participating in a large multiple-case breast cancer family cohort study who were at increased risk for ovarian and fallopian tube cancer (i.e. BRCA1 or BRCA2 mutation carrier or family history including at least one first- or second-degree relative with ovarian or fallopian tube cancer), with no personal history of cancer and with at least one ovary in situ at cohort enrolment, were eligible for this study. Women who knew they did not carry the BRCA1 or BRCA2 mutation segregating in their family (true negatives) were excluded. Sociodemographic, biological and psychosocial factors, including cancer-specific anxiety, perceived ovarian cancer risk, optimism and social support, were assessed using self-administered questionnaires and interviews at cohort enrolment. RRSO uptake was self-reported every three years during systematic follow-up. Of 2,859 women, 571 were eligible. Mean age was 43.3 years; 62 women (10.9 %) had RRSO a median of two years after cohort entry. Factors predicting RRSO were: being parous (OR 3.3, p = 0.015); knowing one’s mutation positive status (OR 2.9, p < 0.001) and having a mother and/or sister who died from ovarian cancer (OR 2.5, p = 0.013). Psychological variables measured at cohort entry were not associated with RRSO. These results suggest that women at high risk for ovarian cancer make decisions about RRSO based on risk and individual socio-demographic characteristics, rather than in response to psychological factors such as anxiety.
Appendix
Available only for authorised users
Literature
1.
go back to reference Antoniou A et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130PubMedCrossRef Antoniou A et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130PubMedCrossRef
2.
go back to reference Rebbeck T, Kauff N, Domchek S (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingooophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101:80–87PubMedCrossRef Rebbeck T, Kauff N, Domchek S (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingooophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101:80–87PubMedCrossRef
3.
go back to reference Cancer Australia, Recommendations for management of women at high risk for ovarian cancer September 2011, Cancer Australia: Canberra Cancer Australia, Recommendations for management of women at high risk for ovarian cancer September 2011, Cancer Australia: Canberra
4.
go back to reference Debeau L (2008) The cell of origin of ovarian epithelial tumours. Lancet 9:1191–1197CrossRef Debeau L (2008) The cell of origin of ovarian epithelial tumours. Lancet 9:1191–1197CrossRef
5.
go back to reference Antill Y et al (2006) Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer. Eur J Cancer 42(5):621–628PubMedCrossRef Antill Y et al (2006) Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer. Eur J Cancer 42(5):621–628PubMedCrossRef
6.
go back to reference Julian-Reynier C et al (2010) Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics. Genet Med 12(12):801–807PubMedCrossRef Julian-Reynier C et al (2010) Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics. Genet Med 12(12):801–807PubMedCrossRef
7.
go back to reference Metcalfe K et al (2008) Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation. Clin Genet 73(5):474–479PubMedCrossRef Metcalfe K et al (2008) Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation. Clin Genet 73(5):474–479PubMedCrossRef
8.
go back to reference Madalinska JB et al (2006) The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy. J Clin Oncol 24(22):3576–3582PubMedCrossRef Madalinska JB et al (2006) The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy. J Clin Oncol 24(22):3576–3582PubMedCrossRef
9.
go back to reference Evans D et al (2009) Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent. Cancer Epidemiol Biomark Prev 18:2318–2324CrossRef Evans D et al (2009) Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent. Cancer Epidemiol Biomark Prev 18:2318–2324CrossRef
10.
go back to reference Scheier MF, Carver CS (1985) Optimism, coping and health: assessment and implications of generalized outcome expectancies. Health Psychol 4(3):219–247PubMedCrossRef Scheier MF, Carver CS (1985) Optimism, coping and health: assessment and implications of generalized outcome expectancies. Health Psychol 4(3):219–247PubMedCrossRef
11.
go back to reference Broadhead W et al (1988) The Duke-UNC functional social support questionnaire. Med Care 26(7):709–722PubMedCrossRef Broadhead W et al (1988) The Duke-UNC functional social support questionnaire. Med Care 26(7):709–722PubMedCrossRef
12.
go back to reference Schwartz MD et al (2003) Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing. J Clin Oncol 21(21):4034–4041PubMedCrossRef Schwartz MD et al (2003) Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing. J Clin Oncol 21(21):4034–4041PubMedCrossRef
13.
go back to reference Hatcher MB, Fallowfield L, A’Hern R (2001) The psychological impact of prophylactic mastectomy: prospective study using questionnaires and semistructured interviews. Br Med J 322(322):76–79CrossRef Hatcher MB, Fallowfield L, A’Hern R (2001) The psychological impact of prophylactic mastectomy: prospective study using questionnaires and semistructured interviews. Br Med J 322(322):76–79CrossRef
14.
go back to reference Phillips K-A et al (2005) Predictors of participation in clinical and psychosocial follow up of the kConFab breast cancer family study. Fam Cancer 4(2):105–113PubMedCrossRef Phillips K-A et al (2005) Predictors of participation in clinical and psychosocial follow up of the kConFab breast cancer family study. Fam Cancer 4(2):105–113PubMedCrossRef
15.
go back to reference Mann G et al (2006) Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 8:R12PubMedCrossRef Mann G et al (2006) Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 8:R12PubMedCrossRef
16.
go back to reference Antoniou A et al (2008) The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer 98:1457–1466PubMedCrossRef Antoniou A et al (2008) The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer 98:1457–1466PubMedCrossRef
17.
go back to reference Horowitz M, Wilner N, Alvarez W (1979) Impact of events scale: a measure of subjective stress. Psychosom Med 41:209–218PubMed Horowitz M, Wilner N, Alvarez W (1979) Impact of events scale: a measure of subjective stress. Psychosom Med 41:209–218PubMed
18.
go back to reference Hosmer D, Lemeshow S (2000) Applied logistic regression, 2nd edn. Wiley, TorontoCrossRef Hosmer D, Lemeshow S (2000) Applied logistic regression, 2nd edn. Wiley, TorontoCrossRef
19.
go back to reference Cohen J (1988) Statistical power analysis for the behavioural sciences, 2nd edn. Academic Press, New York Cohen J (1988) Statistical power analysis for the behavioural sciences, 2nd edn. Academic Press, New York
20.
go back to reference Frost M (2002) Symposium on clinical significance of quality of life measures in cancer patients. Mayo Proceedings 77: 488–494 Frost M (2002) Symposium on clinical significance of quality of life measures in cancer patients. Mayo Proceedings 77: 488–494
21.
go back to reference Miller S et al (2010) New strategies in risk-reducing salpingo-oophorectomy: uptake and experience of women at high risk of ovarian cancer who are considering risk-reducing salpingo-oophorectomy. Clin Cancer Res 16(21):5094–5106PubMedCrossRef Miller S et al (2010) New strategies in risk-reducing salpingo-oophorectomy: uptake and experience of women at high risk of ovarian cancer who are considering risk-reducing salpingo-oophorectomy. Clin Cancer Res 16(21):5094–5106PubMedCrossRef
22.
go back to reference Meiser B et al (1999) Attitudes to prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer. Gynecol Oncol 75:122–129PubMedCrossRef Meiser B et al (1999) Attitudes to prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer. Gynecol Oncol 75:122–129PubMedCrossRef
23.
go back to reference Meiser B et al (2003) Attitudes to prophylactic strategies in Australian women at increased risk for breast cancer. J Women’s Health 12(8):769–778CrossRef Meiser B et al (2003) Attitudes to prophylactic strategies in Australian women at increased risk for breast cancer. J Women’s Health 12(8):769–778CrossRef
24.
go back to reference Meiser B et al (2000) Intention to undergo prophylactic mastectomy in women at increased risk of developing hereditary breast cancer. J Clin Oncol 18(11):2250–2257PubMed Meiser B et al (2000) Intention to undergo prophylactic mastectomy in women at increased risk of developing hereditary breast cancer. J Clin Oncol 18(11):2250–2257PubMed
25.
go back to reference McQuirter M et al (2010) Decision-making process of women carrying a BRCA1 or BRCA2 mutation who have chosen prophylactic mastectomy. Oncol Nurs Forum 37(3):313–320PubMedCrossRef McQuirter M et al (2010) Decision-making process of women carrying a BRCA1 or BRCA2 mutation who have chosen prophylactic mastectomy. Oncol Nurs Forum 37(3):313–320PubMedCrossRef
26.
go back to reference Taylor S (1983) Adjustment to threatening events: a theory of cognitive adaptation. Am Psychol 38(11):1162–1174CrossRef Taylor S (1983) Adjustment to threatening events: a theory of cognitive adaptation. Am Psychol 38(11):1162–1174CrossRef
28.
go back to reference Bradbury AR et al (2008) Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers. Genet Med 10(3):161–166PubMedCrossRef Bradbury AR et al (2008) Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers. Genet Med 10(3):161–166PubMedCrossRef
29.
go back to reference Meiser B (2005) Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psycho-Oncology 14:1060–1074PubMedCrossRef Meiser B (2005) Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psycho-Oncology 14:1060–1074PubMedCrossRef
30.
go back to reference Meiser B et al (2007) International perspectives on genetic counseling and testing for breast cancer risk. Breast Dis 27:109–125 Meiser B et al (2007) International perspectives on genetic counseling and testing for breast cancer risk. Breast Dis 27:109–125
31.
go back to reference Julian-Reynier C et al (2000) Physicians’ attitudes towards mammography and prophylactic surgery for hereditary breast/ovarian cancer risk and subsequently published guidelines. Eur J Hum Genet 8:204–208PubMedCrossRef Julian-Reynier C et al (2000) Physicians’ attitudes towards mammography and prophylactic surgery for hereditary breast/ovarian cancer risk and subsequently published guidelines. Eur J Hum Genet 8:204–208PubMedCrossRef
32.
go back to reference Julian-Reynier CM et al (2001) Women’s attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: differences among English, French, and Canadian women. Cancer 92(4):959–968PubMedCrossRef Julian-Reynier CM et al (2001) Women’s attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: differences among English, French, and Canadian women. Cancer 92(4):959–968PubMedCrossRef
Metadata
Title
Psychosocial factors and uptake of risk-reducing salpingo-oophorectomy in women at high risk for ovarian cancer
Authors
Bettina Meiser
Melanie A. Price
Phyllis N. Butow
Janan Karatas
Judy Wilson
Louise Heiniger
Brandi Baylock
Margaret Charles
Sue-Anne McLachlan
Kelly-Anne Phillips
Publication date
01-03-2013
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 1/2013
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-012-9585-8

Other articles of this Issue 1/2013

Familial Cancer 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine